FDA NDC Directory · JSON-LD · Markdown

Naproxen

NDC 59651-986 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA075390
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsNAPROXEN (375 mg/1)
Marketing started20250508
Package count2

External sources

Source: openFDA. Public-domain (CC0).